The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following abiraterone and/or enzalutamide (abi/enz).
 
Daniel Peter Petrylak
Research Funding - Progenics (Inst)
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Endocyte; Mannkind; UpToDate
Consulting or Advisory Role - Amgen; AVEO; BIND Biosciences; Janssen Biotech
Speakers' Bureau - Bayer; Caris MPI; Dendreon; GlaxoSmithKline; Medivation; Millennium; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
Gurkamal S. Chatta
Research Funding - Progenics (Inst)
 
Mark T. Fleming
Research Funding - Progenics (Inst)
 
David C. Smith
Research Funding - Abraxis BioScience (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Atterocor (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); ImClone Systems (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Millennium (Inst); Oncogenex (Inst); OncoMed (Inst); PSMA Development Company (Inst); Tekmira (Inst); Teva (Inst)
 
Leonard Joseph Appleman
Research Funding - Astellas Pharma; Bayer; Johnson & Johnson; Medivation; Novartis; Pfizer; Progenics (Inst); Sotio
 
Arif Hussain
No Relationships to Disclose
 
Manuel Modiano
Research Funding - Progenics (Inst)
 
Parminder Singh
Consulting or Advisory Role - Progenics (Inst)
Research Funding - Progenics (Inst)
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Janssen (Inst); Lilly (Inst); Millennium/Prometrika (Inst); Progenics (Inst); Sanofi (Inst)
 
Ira Gore
Research Funding - Progenics (Inst)
 
Edward Francis McClay
Honoraria - Caris Life Sciences; Genentech
Consulting or Advisory Role - Caris Life Sciences; Genentech
Speakers' Bureau - Genentech
Research Funding - Progenics (Inst)
 
Anthony E. Mega
Research Funding - Progenics (Inst)
 
A. Oliver Sartor
Research Funding - Progenics (Inst)
 
Bradley G. Somer
Research Funding - Progenics (Inst)
 
Raymond Couric Wadlow
Research Funding - Progenics (Inst)
 
Neal D. Shore
Research Funding - Progenics (Inst)
 
Nancy Stambler
Employment - Progenics
Stock and Other Ownership Interests - Progenics
Research Funding - Progenics
 
Vincent A. DiPippo
Employment - Progenics
Stock and Other Ownership Interests - Progenics
Research Funding - Progenics
Patents, Royalties, Other Intellectual Property - Progenics
 
Robert Joseph Israel
Employment - Progenics
Leadership - Progenics
Stock and Other Ownership Interests - Progenics
Research Funding - Progenics
Patents, Royalties, Other Intellectual Property - Progenics